OncoVista Innovative Therapies, Inc.
OncoVista Innovative Therapies, Inc.
Your view on OVIT
Overview
What the company does, where it operates, and who runs it.
About OncoVista Innovative Therapies, Inc.
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Alexander L. Weis
- Headquarters
- 14785 Omicron Drive, San Antonio, TX, US
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Alexander L. Weis
- Headquarters
- 14785 Omicron Drive, San Antonio, TX, US
OncoVista Innovative Therapies, Inc., a biopharmaceutical company, develops targeted anticancer therapies by utilizing tumor-associated biomarkers. The company's product candidates include Cordycepin (OVI-123), which is in Phase I/II clinical trials for the treatment of refractory TdT positive leukemias; and L-Nucleoside Conjugates (OVI-117) that is under pre-clinical development for the treatment of colon cancer. The company was founded in 2004 and is based in San Antonio, Texas.
Infographics
Visual summary of the business at a glance.
Media
Videos and interviews covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks the stock is worth vs. the current price.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Comparables
List of peer companies in the same industry.
Institutional Ownership
Which funds and firms own the stock.
Insider Trading
Recent buying and selling by company executives.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
News
Latest headlines and market coverage.